[A new family of synthetic immunoregulators: muramyl dipeptide and its analogs]. 1978

L Chedid, and F Audibert, and M Parant

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D009112 Muramic Acids Compounds consisting of glucosamine and lactate joined by an ether linkage. They occur naturally as N-acetyl derivatives in peptidoglycan, the characteristic polysaccharide composing bacterial cell walls. (From Dorland, 28th ed) Muramic Acid,Acid, Muramic,Acids, Muramic
D005620 Freund's Adjuvant An antigen solution emulsified in mineral oil. The complete form is made up of killed, dried mycobacteria, usually M. tuberculosis, suspended in the oil phase. It is effective in stimulating cell-mediated immunity (IMMUNITY, CELLULAR) and potentiates the production of certain IMMUNOGLOBULINS in some animals. The incomplete form does not contain mycobacteria. Freund Adjuvant,Adjuvant, Freund,Adjuvant, Freund's,Freunds Adjuvant
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants

Related Publications

L Chedid, and F Audibert, and M Parant
April 1983, Infection and immunity,
L Chedid, and F Audibert, and M Parant
January 1978, Antibiotics and chemotherapy,
L Chedid, and F Audibert, and M Parant
November 1989, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
L Chedid, and F Audibert, and M Parant
January 1985, Microbiology and immunology,
L Chedid, and F Audibert, and M Parant
August 1989, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
L Chedid, and F Audibert, and M Parant
February 1982, Infection and immunity,
L Chedid, and F Audibert, and M Parant
July 1981, Cellular immunology,
L Chedid, and F Audibert, and M Parant
August 1985, Biulleten' eksperimental'noi biologii i meditsiny,
L Chedid, and F Audibert, and M Parant
February 1978, Biochemical and biophysical research communications,
L Chedid, and F Audibert, and M Parant
October 1978, Experientia,
Copied contents to your clipboard!